TD2 Works Closely with ZIOPHARM Oncology to Conduct a Preclinical Study Presented at the Annual Society for Neuro-Oncology Meeting in Houston, TX

November 21, 2016

Ziopharm presents preclinical data generated by TD2; Local Regulated IL-12 Expression as an Immunotherapy for the Treatment of Pontine Glioma.  See attached poster.